
Building Quinn, an AI scientist accelerating pharma/biotech R&D
iollo is building Quinn, an AI scientist that automates the entire drug development lifecycle, from target discovery to commercial strategy. Quinn synthesizes scientific, clinical, and market data to execute complex R&D workflows in hours that typically take pharma teams years.
GPAgent keeps YC listings public and neutral. Fund-specific scoring, notes, and workflow state live in each customer workspace.
Join the GPAgent waitlist